ABBV-2-19-19

ABBV – may rally to $93 – $97. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. AbbVie Inc is a drug company with a strong exposure to immunology and oncology. The company’s top Read more…

Login